A newly approved higher-dose Wegovy underscores how fast obesity treatment is evolving—while India prepares for lower-cost GLP-1 options as patents shift. Here’s what the changes may mean for access, safety, and expectations.
GLP‑1 weight-loss medications are reshaping treatment options, food shopping habits, and healthcare costs. Here’s how to protect bone health during weight loss and what recent policy and dosing developments could mean for patients.
A wave of weight-loss headlines points to rapid progress—and real pressure—around GLP-1 medications, pricing, and long-term health needs like bone protection. Here’s what the latest reports suggest and what to consider if you’re trying to lose weight safely.
A practical, science-aware look at the latest weight-loss headlines—from protein-forward snacking to emerging medications inspired by biology and new clinical trial results.
A practical overview of three major weight-loss storylines: dangerous supplement contamination, realistic snack strategies, and emerging medications inspired by new biology research.
Weight loss is increasingly shaped by medications, mental health findings, and age-specific care needs. Here’s a practical, evidence-informed guide to safer expectations and smarter habits—especially for people using GLP-1 drugs or managing obesity later in life.
New reports suggest GLP-1 weight-loss injections may be linked with improved anxiety and depression symptoms, but results vary and stopping treatment can lead to rapid regain. Here’s what the evidence likely means, how to compare common medications, and how to avoid misleading weight-loss claims.
A practical overview of today’s weight-loss injections—what the latest reporting suggests about access and mental health, why weight often returns after stopping, how semaglutide compares with tirzepatide, and how to spot misleading ads.
New reporting highlights that many people discontinue GLP‑1 weight-loss medications within a year. Here’s why that happens, what it can mean for weight and heart health, and how workouts, nutrition, and mental health support can help maintain progress.
GLP‑1 medications can help with weight loss, but many people stop within a year and may regain weight. Here’s how to set realistic workout expectations, protect your mental health, and plan a safer long-term strategy with your clinician.
GLP-1 weight-loss medicines are reshaping obesity care, from new oral candidates and cheaper generics to the realities of weight regain after stopping. Here’s what the latest headlines suggest—and how to use these tools safely within a long-term health plan.
New reporting suggests GLP-1 weight-loss drugs may help preserve some weight loss after discontinuation, but emerging evidence raises important safety concerns for pregnancy—especially in women with pre-existing diabetes.